tradingkey.logo
tradingkey.logo
Search

X T L Biopharmaceuticals Ltd

XTLB
Add to Watchlist
2.810USD
-0.040-1.40%
Close 07-31 16:00ETQuotes delayed by 15 min
6.19MMarket Cap
LossP/E TTM

XTLB Financials

See X T L Biopharmaceuticals Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

X T L Biopharmaceuticals Ltd Earnings Date

Latest Release
Jun 30, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
-100.00%
EPS(YoY)
-0.78
-408.50%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2016Q2
FY2016Q1
FY2015Q4
FY2015Q3
FY2015Q2
FY2014Q4
FY2014Q3
FY2014Q2
FY2014Q1
FY2013Q4
FY2013Q3
FY2013Q2
FY2013Q1
FY2012Q4
FY2012Q3
FY2012Q2
FY2012Q1
Financial Indicators
EPS
----
----
----
43.14%-0.03
-97.44%-0.08
-92.54%-0.13
152.66%0.09
62.77%-0.05
74.17%-0.04
-28.85%-0.07
---0.17
---0.14
---0.15
---0.05
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
----
----
----
--289.00K
--162.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
----
----
----
10.21%-255.00K
-157.21%-553.00K
-93.41%-704.00K
152.77%485.00K
62.03%-284.00K
73.81%-215.00K
-27.72%-364.00K
-281.62%-919.00K
---748.00K
---821.00K
---285.00K
--506.00K
-273.95%-1.97M
53.06%-590.00K
85.14%-424.00K
-99.30%27.00K
-150.24%-526.00K
-222.04%-1.26M
-8494.12%-2.85M
342.74%3.87M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Margin
----
----
----
---88.24%
---341.36%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
----
----
----
---14.88%
--28.40%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
9939.91%162.05%
--12.04%
----
--1.61%
--1.81%
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
----
----
----
--289.00K
--162.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
----
----
----
-306.00%-812.00K
-405.96%-764.00K
-158.28%-421.00K
30.28%-175.00K
11.11%-200.00K
25.98%-151.00K
19.31%-163.00K
-0.80%-251.00K
---225.00K
---204.00K
---202.00K
---249.00K
-5.33%-257.00K
-9.05%-217.00K
-8.50%-217.00K
-29.15%-257.00K
-10.41%-244.00K
-4.74%-199.00K
-8.70%-200.00K
-0.51%-199.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
----
----
----
10.21%-255.00K
-157.21%-553.00K
-93.41%-704.00K
152.77%485.00K
62.03%-284.00K
73.81%-215.00K
-27.72%-364.00K
-281.62%-919.00K
---748.00K
---821.00K
---285.00K
--506.00K
-273.95%-1.97M
53.06%-590.00K
85.14%-424.00K
-99.30%27.00K
-150.24%-526.00K
-222.04%-1.26M
-8494.12%-2.85M
342.74%3.87M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Current assets
-87.61%166.00K
-73.59%533.00K
----
-34.51%1.34M
-12.97%1.99M
-19.31%2.02M
-13.39%2.55M
-46.24%2.05M
-49.46%2.28M
-53.48%2.50M
-52.85%2.94M
--3.81M
--4.52M
--5.38M
--6.24M
-10.38%6.12M
-14.67%5.83M
-30.09%6.41M
-42.86%6.89M
-16.66%6.83M
-3.65%6.83M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Total current liabilities
-80.97%420.00K
361.21%761.00K
----
971.36%2.21M
1422.84%2.47M
1.23%165.00K
-7.47%223.00K
10.16%206.00K
5.88%162.00K
-5.23%163.00K
-7.31%241.00K
--187.00K
--153.00K
--172.00K
--260.00K
-100.00%0.00
----
-4.43%194.00K
3.39%244.00K
-8.30%232.00K
17.77%232.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Total assets
-98.06%166.00K
-70.23%714.00K
----
252.43%8.55M
248.48%9.28M
-16.77%2.40M
-11.86%2.93M
-42.04%2.43M
-45.62%2.66M
-49.96%2.88M
-49.83%3.32M
--4.19M
--4.90M
--5.76M
--6.62M
-9.83%6.50M
-13.89%6.21M
-28.90%6.79M
-41.54%7.27M
-15.90%7.21M
-3.44%7.21M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Total liabilities
-86.52%420.00K
361.21%761.00K
----
1412.14%3.12M
2099.38%3.56M
1.23%165.00K
-7.47%223.00K
10.16%206.00K
5.88%162.00K
-15.98%163.00K
-68.98%241.00K
--187.00K
--153.00K
--194.00K
--777.00K
-100.00%0.00
-21.55%182.00K
-4.43%194.00K
3.39%244.00K
-8.30%232.00K
17.77%232.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Total equity
-104.67%-254.00K
-102.10%-47.00K
----
144.82%5.43M
128.59%5.72M
-17.84%2.23M
-12.20%2.71M
-44.49%2.22M
-47.28%2.50M
-51.14%2.72M
-47.28%3.08M
--4.00M
--4.74M
--5.56M
--5.84M
-48.25%3.61M
-13.64%6.03M
-29.43%6.59M
-42.41%7.03M
-16.13%6.98M
-4.02%6.98M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net operating income
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
1.17%-508.00K
---657.00K
26.11%-498.00K
3.74%-438.00K
5.51%-514.00K
-29.62%-674.00K
39.97%-455.00K
18.56%-544.00K
-44.12%-797.00K
-27.45%-520.00K
-60.93%-758.00K
-94.19%-668.00K
-95.41%-553.00K
---408.00K
---471.00K
---344.00K
---283.00K
Net investment
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
107.14%1.00K
---65.00K
-110.47%-54.00K
-137.95%-63.00K
-102.60%-14.00K
154.60%516.00K
-95.61%166.00K
18033.33%538.00K
-44.42%279.00K
-29.63%-945.00K
2263.75%3.78M
99.81%-3.00K
-48.83%502.00K
---729.00K
--160.00K
---1.62M
--981.00K
Net financing
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
--0.00
--20.00K
-100.00%0.00
5292.42%3.56M
-100.00%0.00
-89.76%13.00K
633.33%66.00K
2455.56%230.00K
109.76%172.00K
-67.85%127.00K
-75.00%9.00K
-99.76%9.00K
--82.00K
--395.00K
--36.00K
--3.77M

FAQs

What are the current assets of X T L Biopharmaceuticals Ltd?

According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its current assets were 166.00K, with a year-on-year change of -87.61.

What are the total assets of X T L Biopharmaceuticals Ltd?

According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its total assets of X T L Biopharmaceuticals Ltd were 166.00K, with a year-on-year change of -98.06.

What are the total liabilities of X T L Biopharmaceuticals Ltd?

According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its total liabilities of X T L Biopharmaceuticals Ltd were 420.00K, with a year-on-year change of -86.52.

What is the total equity of X T L Biopharmaceuticals Ltd?

According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its total equity of X T L Biopharmaceuticals Ltd was -254.00K, with a year-on-year change of -104.67.

What is the net operating income of X T L Biopharmaceuticals Ltd?

According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its net operating income of X T L Biopharmaceuticals Ltd was -1.47M, with a year-on-year change of 32.55.

What is the net investment of X T L Biopharmaceuticals Ltd?

According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its net investment of X T L Biopharmaceuticals Ltd was 522.00K, with a year-on-year change of 159.45.

What is the net financing of X T L Biopharmaceuticals Ltd?

According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its net financing of X T L Biopharmaceuticals Ltd was 208.00K, with a year-on-year change of -85.63.

What is the Earnings Per Share (EPS) of X T L Biopharmaceuticals Ltd?

According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -0.78, with a year-on-year change of -408.50.

What is the net income of X T L Biopharmaceuticals Ltd?

According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its net income was -6.97M, with a year-on-year change of -578.58.

What is the debt-to-asset ratio of X T L Biopharmaceuticals Ltd?

According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its debt-to-asset ratio was 162.05, with a year-on-year change of 9939.91.

What is the Return on Equity (ROE) of X T L Biopharmaceuticals Ltd?

According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its Return on Equity (ROE) was -29.30, with a year-on-year change of -9.20.

What is the Return on Assets (ROA) of X T L Biopharmaceuticals Ltd?

According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its Return on Assets (ROA) was -17.42, with a year-on-year change of 6.93.

What is the operating profit of X T L Biopharmaceuticals Ltd?

According to X T L Biopharmaceuticals Ltd's FY2025 earnings report, its operating profit was -1.47M, with a year-on-year change of 32.55.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.